Alfred P. Spada serves as Executive at Conatus Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Alfred P. Spada has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 22, 2020 involved selling 12,960 shares valued at $7.3K.
Alfred P. Spada currently holds 19,595 shares of Conatus Pharmaceuticals Inc (CNAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alfred P. Spada has been a net neutral trader of CNAT stock. They have purchased $0 and sold $0 worth of shares.
Alfred P. Spada's most recent insider trade was on May 22, 2020, when they sold 12,960 shares at $0.56 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 27, 2018 | CNAT | $15.0K | Option Exercise | 12,121 | $1.24 | Discretionary |
| Jul 30, 2013 | CNAT | $0 | Conversion | 44,112 | $N/A | Discretionary |